Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
151.86
+1.29 (0.86%)
At close: Dec 5, 2025, 4:00 PM EST
152.00
+0.14 (0.09%)
Pre-market: Dec 8, 2025, 4:00 AM EST
Molina Healthcare Stock Forecast
Stock Price Forecast
According to 12 professional analysts, the 12-month price target for Molina Healthcare stock ranges from a low of $144 to a high of $345. The average analyst price target of $205.67 forecasts a 35.43% increase in the stock price over the next year.
Price Target: $205.67 (+35.43%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Molina Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 10 | 9 | 9 | 9 | 9 | 9 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 12 | 12 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $231 → $165 | Buy | Maintains | $231 → $165 | +8.65% | Nov 12, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $207 → $167 | Hold | Maintains | $207 → $167 | +9.97% | Oct 24, 2025 |
| UBS | UBS | Hold Maintains $180 → $170 | Hold | Maintains | $180 → $170 | +11.95% | Oct 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $210 → $180 | Hold | Maintains | $210 → $180 | +18.53% | Oct 24, 2025 |
| Barclays | Barclays | Hold → Sell Downgrades $185 → $144 | Hold → Sell | Downgrades | $185 → $144 | -5.18% | Oct 24, 2025 |
Financial Forecast
Revenue This Year
45.17B
from 39.16B
Increased by 15.34%
Revenue Next Year
47.18B
from 45.17B
Increased by 4.44%
EPS This Year
14.40
from 20.42
Decreased by -29.46%
EPS Next Year
13.57
from 14.40
Decreased by -5.82%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.6B | 50.1B | |||
| Avg | 45.2B | 47.2B | |||
| Low | 41.7B | 44.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.6% | 10.9% | |||
| Avg | 15.3% | 4.4% | |||
| Low | 6.3% | -2.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.37 | 15.21 | |||
| Avg | 14.40 | 13.57 | |||
| Low | 13.23 | 10.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.1% | 5.6% | |||
| Avg | -29.5% | -5.8% | |||
| Low | -35.2% | -25.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.